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Abstract 
Calretinin is a Ca2+-binding protein of the EF-hand family which is expressed incolon adenocarcinomas and colon-derived tumor cell 
lines (e.g. WiDr), but is absent from normal human enterocytes. Its function has not as yet been elucidated, but some lines of evidence 
lead us to postulate its involvement in cell proliferation in these cells. In order to test whether calretinin is correlated with an 
undifferentiated, proliferating, or with a differentiated, state of cells, its expression was studied in the human colon adenocarcinoma clonal 
cell line HT29-18, which can be caused to differentiate into enterocyte-like c lls by replacing glucose with galactose in the culture 
medium (glucose starvation differentiation). Treatment of HT29-18 cells with galactose l d to a drop in the calretinin mRNA level and in 
protein expression as evidenced by immunocytochemical staining and Western blot analysis of cytosolic cell extracts. These results 
suggest hat calretinin is present in HT29-18 cancer cells, mostly in those which are in the undifferentiated state. The possibility that 
calretinin is involved in maintaining the cells in an undifferentiated (cancerous) tate is discussed. 
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1. Introduction 
Calretinin (CR), a highly evolutionary conserved EF- 
hand calcium binding protein [1], is expressed mainly in 
distinct subpopulations of nerve cells in the central [2] and 
peripheral nervous ystem [3] of both vertebrate and inver- 
tebrate species. 
Moreover, it has been detected in the interstitial cells of 
the rat ovary [4], in the Leydig cells of rat testis [5] and in 
the avian thymus [6]. The presence of calretinin has been 
also demonstrated in some human cancerous cells, such as 
the colon cancer cell line WiDr [7], and in mesotheliomas 
of the epithelial type [8]. 
The function of this protein is still unknown. In nerve 
cells, calretinin is discussed as a Ca2+-buffer which may 
protect neurons against Ca2+-overload [9]. Rogers [10] has 
suggested that calretinin, besides a buffeting function, may 
play different roles in the cell types which express it. In 
the human colon adenocarcinoma cell line WiDr, a correla- 
tion between the cell cycle and CR-immunoreactivity has 
been observed [7]. 
The homeostasis of normal colonic mucosa is main- 
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tained by the sequence of events which cells normally 
undergo in vivo: proliferation, differentiation, displace- 
ment, apoptosis and extrusion into the colonic lumen 
[11,12]. 
For a long time, the mutations or the epigenetic modifi- 
cations which block the normal maturation of cells to a 
terminal stage (differentiation-death) have been supposed 
to play an important role in the carcinogenesis of several 
tumors [13]. We have observed that normal cells of colonic 
mucosa in situ do not express calretinin, while the colon 
adenocarcinoma cell line HT29 does express it (in prepara- 
tion). This cell line has been widely used as a convenient 
in vitro model to investigate the differentiation process of 
intestinal cells that can be promoted by various culture 
conditions and chemical substances [14-18]. 
In this work we have studied the expression of calre- 
tinin in the multipotent clone 18 of the HT29 cell line 
(HT29-18), which can be differentiated into 'enterocyte- 
like' cells by replacing glucose with galactose in the 
culture medium [14,19]. We have observed that in HT29- 
18/glu cells this protein is expressed, whereas in HT29- 
18/gal cells its expression is decreased. 
The study of calretinin expression in undifferentiated, 
proliferating HT29-18 cells and in differentiated ones, may 
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prove to be helpful in understanding the role of this protein 
in tumoral cell proliferation and eventually in carcino- 
genesis. 
plane of cell growth using a Reichert ultramicrotome and 
then examined in a Zeiss EM 10 electron microscope. 
Calretinin immunostained samples were prepared for trans- 
mission electron microscopy using the same procedure. 
2. Materials and methods 2.3. Scanning electron microscopy 
2.1. Cell cultures 
The clone HT29-18 was a kind gift from Prof. E. 
Pringault (Institut Pasteur, Paris, France). Cells were seeded 
in Petri dishes, in culture flasks and on Leighton cover- 
slips, either in a glucose-containing medium (HT29- 
18/glu) or in a galactose containing-medium (HT29- 
18/gal), at a concentration of 10 4 cells/ml, and then 
cultured at 37°C in 5% CO2/95% air. Cells were 
trypsinized with 0.25% trypsin in Ca 2+ and MgZ+-free 
phosphate-buffered saline (CMF-PBS) (pH 7.2). 
HT29-18/glu cells were grown in Dulbecco's MEM 
(25 mM glucose) (Seromed ®) supplemented with 10% 
heat-inactivated fetal calf serum (FCS) (Gibco), 2 mM 
L-glutamine, 10 U/ml  penicillin and 10 /zg/ml strepto- 
mycin (all from Gibco), and 10 /xg/ml human transferrin 
(Boehringer Mannheim). The medium was changed aily 
in order to maintain the cells in the undifferentiated state. 
The galactose treatment was carried out following the 
protocol of Huet [19]. 
HT29-18/gal cells were grown in glucose-free Dul- 
becco's MEM supplemented with 10% FCS, dialyzed 
against 0.9% NaC1 (Spectra/Por e Membrane, cutoff 
6000-8000 Da; Spectrum Medical Industries, USA), 2 
mM glutamine, 10 U/ml  penicillin and 10/xg/ml strepto- 
mycin, and 10 /zg/ml human transferrin. Glucose at pro- 
gressively lower, and galactose at progressively higher 
concentrations were added to the medium over the first 5 
days of culture (day 0, 20 mM glucose + 1 mM galactose; 
day 1, 15 mM glucose + 1 mM galactose; day 2, 10 mM 
glucose + 3 mM galactose; day 3, 5 mM glucose + 4 mM 
galactose; day 4, 5 mM galactose); 5 mM galactose-con- 
taining medium was then changed twice a week. 
HT29-18/glu cells were fixed for electron microscopy 
and immunostaining, or harvested for RNA isolation or 
Western blot analysis, 7 days after seeding, when they 
were still subconfluent and covered approx. 70% of the 
surface of Petri dishes or culture flasks. HT29-18/gal cells 
were fixed or harvested after 26 days in galactose-contain- 
ing medium. 
2.2. Transmission electron microscopy 
Samples from Petri dishes were fixed with 2.5% glu- 
taraldehyde in 0.1 M phosphate buffer (pH 7.2), postfixed 
with 1% OsO 4 in 0.1 M phosphate buffer, dehydrated in a 
graded series of increasing ethanol concentrations and 
embedded in Epon 812. After polymerization (48 h at 
60-65°C) ultrathin sections were cut perpendicular to the 
Scanning electron microscopy was carried out on cul- 
tures grown on coverslips. After fixation with 2.5% glu- 
taraldehyde in 0.1 M phosphate buffer (pH 7.2) samples 
were postfixed with 1% OsO 4 in 0.1 M phosphate buffer 
and dehydrated in a graded series of increasing acetone 
concentrations, transferred into a critical point dryer (Bal- 
zers, CPD 030), coated with platinum (coating unit Balz- 
ers, BA 080) and finally viewed with a scanning electron 
microscope (Jeol, 6300 F). 
2.4. lmmunocytochemistry 
The cells, grown in Petri dishes, were washed in CMF- 
PBS (pH 7.2) and fixed for 30 min at room temperature in 
a mixture of 4% paraformaldehyde, 15% (v/v)  saturated 
picric acid, and 0.38% glutaraldehyde, in 0.1 M Tris- 
buffered saline (TBS) (pH 7.3). They were washed with 
TBS and then incubated overnight at 4°C with a polyclonal 
antibody against calretinin (7696, Swant [20]) diluted 
1:5000 in TBS containing 10% of bovine serum. The 
samples were washed again and then incubated with the 
secondary antibody, diluted 1:200 (biotinylated goat anti- 
rabbit IgG) for 2 h at room temperature. They were 
washed once more before incubation for 3 h at room 
temperature with the avidin-biotin complex (Vector Labo- 
ratories, Burlingame, CA), diluted 1:200. The antibody 
complex was then visualized by incubation with the sub- 
strate 3,3'-diaminobenzidine (DAB)-HCl-hydrogen perox- 
ide. Control cultures incubated without the first antibody 
did not exhibit immunostaining. 
Immunofluorescence was used to show the expression 
of N-aminopeptidase. The cells were fixed with 4% para- 
formaldehyde in 0.1 M phosphate buffer (pH 7.2), washed 
and then incubated overnight at 4°C with a monoclonal 
antibody against N-aminopeptidase diluted 1:200 in TBS 
containing 10% of bovine serum (the antibody was a 
generous gift of Prof. H.-P. Hauri, Biozentrum, Basle, 
Switzerland). After washing, an anti-mouse IgG coupled 
with fluorescein (Molecular Probes, USA) was used as 
secondary antibody. Control cultures incubated without he 
first antibody did not exhibit immunofluorescence. 
2.5. Western blot analysis 
Cells, grown in 75 cm 2 culture flasks, were harvested, 
washed in CMF-PBS and centrifuged. The pellets were 
disrupted by ultrasonication (Micro Ultrasonic Disrupter, 
Kontes) for 20 s, on ice. The suspension was then cen- 
trifuged (18000 ×g,  4°C, 30 min) and the supernatant 
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used for SDS-gel electrophoresis followed by Western 
blotting. Protein concentrations of samples were deter- 
mined by the method of Bradford [21] (reagent from 
Bio-Rad). Protein samples were diluted to the same con- 
centration and proteins were separated by SDS-PAGE 
(Hoefer Scientific Instruments, USA), transferred onto ni- 
trocellulose membranes (BDH, UK), which were then 
saturated with blocking buffer (1% bovine serum albumine 
and 10% bovine serum) and incubated with calretinin 
antibody (1:1000). A peroxidase bound goat anti-rabbit 
secondary antibody (1:1000) was added in a second step 
and the complex revealed by the chromogen chlornaph- 
thol/hydrogen peroxide. 
2.6. Northern blot analysis 
Total RNA from HT29-18 (glu or gal) cells was iso- 
lated by the AGPC method [22] and 10 ~g of total RNA 
were separated on a 1% formaldehyde agarose gel and 
transferred onto nylon membranes (Zeta Probe, Bio-Rad). 
The RNA was fixed on the membranes with the UV- 
Stratalinker (Stratagene, USA) and the membranes were 
prehybridized in 15 ml QuikHyb Rapid ~ Hybridization 
Solution (Stratagene). For the probe, a cDNA fragment 
(EcoRI-HindIII) of calretinin clone 3.6 (1500 bp) [20] 
was used. This fragment which contains almost he entire 
sequence of the human CR mRNA was random labelled 
with the Prime-It II kit (Stratagene) using [32p]dCTP. The 
specific activity was approx. 108 cpm//~g DNA. The 
membranes were incubated with 10 6 cpm/ml hybridiza- 
tion solution and hybridized overnight at 42°C. They were 
washed with 2 X SSC, 0.1% SDS (2 X 30 min, RT), fol- 
lowed by 0.1 X SSC, 0.1% SDS (1 X 20 rain, 60°C). The 
membranes were placed in a cassette quipped with 2 
intensifying screens and exposed to X-ray film (BioMax 
MS, Kodak) at -70°C overnight. Additionally, the ra- 
dioactive bands on the membranes were quantified on a 
PhosphorImager system (Molecular Dynamics, USA). 
2.7. DNA cytophotometry and mitotic index 
Cells were fixed with ethanol (95%)/acetic acid (3:1, 
v/v) at 4°C for 24 h. Feulgen's reaction was carded out by 
hydrolysis with 1 M HC1 at 56°C for 20 min. Using a 
Fig. 1. Scanning (a, b, d) and transmission (c) electron microscopy micrographs of HT29-18/glu and HT29-18/gal cells, (a) Cells grown in 
glucose-containing medium for 7 days; irregular microvilli, but no brush borders are visible at the surface of cells. (b, c, d) Cells grown in 
galactose-containing medium for 26 days; regularly spaced microvilli can be observed on the apical surface of the cells. (c) Granules filled with a fuzzy 
material can be found at the apical pole of the cells (arrows). Scale bars: a, b: l0 /xm; c: 0.5 /~m; d: 1 /~m. 
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scanning microdensitometer (Wikers, M 86; 100 X,  oil), at 
a wavelength of 547 nm, the relative amount of DNA was 
determined for each cell. For the quantification of both 
HT29-18/glu and HT29-18/gal  cells, at least 300 cells 
were counted. The percentage of cells in phase G1, S or 
G2 was calculated according to the method of Dean [23]. 
The mitotic index was calculated by counting a minimum 
of 3000 cells for each experiment. 
3. Results 
After 26 days in galactose-containing medium the cells 
were confluent. Scanning and transmission electron mi- 
croscopy revealed that cells displayed characteristics of 
differentiated enterocytes (Fig. lb,c). Regularly spaced 
microvilli were visible at the apical membrane of the 
majority of cells (Fig. ld). Some cells were organized 
around a hollow structure and their microvilli were di- 
rected towards the interior of the cavity (Fig. 2b). Such 
structures uggested the presence of adenomatoid organ- 
otypic formations. We could also observe belt-like anchor- 
ing junctions encircling adjacent cells (Fig. 2b). 
3.1. Cell morphology 3.2. Immunohistochemistry 
HT29-18/glu cells grow as undifferentiated epithelioid 
cells. Transmission and scanning electron microscopy 
showed that after 7 days of culturing, cells presented 
irregular microvilli and membrane folds at their surfaces, 
but no brush borders (Fig. la). 
During the first two weeks of galactose treatment a 
large number of cells died: the nuclear fragmentation, in
the form of chromatin condensed masses, present in sev- 
eral cells, is suggestive of an apoptotic ell death (Fig. 2a). 
From the first week of treatment some intercellular 
vacuole-like structures could be observed by phase con- 
trast microscopy of living cultures (Fig. 2a). 
The immunofluorescence experiments performed to 
demonstrate the expression of N-aminopeptidase, a marker 
of a differentiated phenotype, showed that after 26 days in 
galactose-containing medium, the majority of cells ex- 
pressed the enzyme (Fig. 3a). On the contrary the enzyme 
was present o a much lesser degree in HT29-18/glu cells 
(Fig. 3b). 
A large number of HT29-18/glu,  undifferentiated cells 
showed a strong calretinin immunoreactivity (about 40% 
of the cells). The positive staining was uniformly dis- 
tributed in the cytoplasm and no nuclear localization was 
found. Immunopositive cells were often observable at the 
Fig. 2. HT29-18/gal cells. (a) After one week of treatment: arrowheads indicate dead cells, asterisks intercellular vacuole-like structures, and arrows cells 
showing signs of apoptosis. The inset shows a semithin section of an HT29-18/gal cell culture, after 26 days of treatment: in some cells, chromatin 
condensed masses (arrow) can be observed, suggesting apoptotic cell death. (b) Transmission electron micrograph ofHT29-18/gal cells after 26 days of 
treatment showing a well developed brush border directed towards an intercellular lumen. The inset shows the apical junctions between adjacent cells. 
Scale bars: a: 10 /xm, inset 3 /zm; b: 1.22 /xm, inset 0.8 /xm. 
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periphery of cell clusters. Moreover, mitotic cells were 
intensely CR-positive (Fig. 3d). In HT29-18/gal, differen- 
tiated cells the percentage of cells displaying calretinin 
immunoreactivity was dramatically decreased (less than 
10% of the cells) (Fig. 3e). Observations by transmission 
electron microscopy of calretinin-immunoreactive HT29- 
18/gal samples revealed that after 26 days of galactose 
treatment, the rare remaining CR-positive cells did not 
show conversion to an enterocytic phenotype. The cell 
surface was quite smooth and microviUi were absent. On 
b 
the contrary, CR-negative cells presented microvilli (Fig. 
3c). 
3.3. Western blot 
Equal amounts of protein (5 /xg) from the cytosolic 
fractions of HT29-18/glu cells, harvested one week after 
seeding, and HT29-18/gal cells, harvested after 26 days in 
galactose-containing medium, were separated on a SDS gel 
and transferred onto a nitrocellulose membrane. Immunos- 
~>>!<ii< ¸¸.¸¸¸i/<7/¸i ! <; % iLt</ !ii!%i[iiiii~i.li:iFi/ 
i~!i!i]ili!i~i[ii!i!ii!!~iJ 
Fig. 3. Immunofluorescence staining of N-aminopeptidase and immunohistochemical st ining of calretinin in HT29-18 cells. (a) N-Aminopeptidase in 
HT29-18/gal cells, after 26 days in galactose medium. (b) N-Aminopeptidase in HT29-18/glu cells, after 7 days in glucose medium. (c) Transmission 
electron microscopy image of a CR-immunoreactive culture: a CR-positive cell, showing an undifferentiated phenotype (right); a CR-negative cell (left), 
presenting microvilli (arrow) on the surface. N = nucleus; M = mitochondria. (d) Calretinin in HT29-18/glu cells. (e) Calretinin in HT29-18/gal cells. 
Scale bars: a, b: 20 /xm; c: 1 /~m; d, e: 8 /zm. 
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A B C 
Fig. 4. Imrnunoblot of cytosolic proteins of HT29-18 cells. Lane A: 
purified recombinant calretinin; lane 13: calretinin in HT29-18/glu cells, 
after 7 days in glucose medium; lane C: calretinin in HT29-18/gal cells, 
after 26 days in galactose medium. The signal for calretinin is weaker in 
HT29-18/gal than in HT29-18/glu cells. 
taining of this membrane using the rabbit serum 7696 
against calretinin showed that the signal for the protein 
was weaker in differentiated HT29-18/gal cells than in 
undifferentiated HT29-18/glu cells (Fig. 4). 
3.4. Northern blot 
The Northern blot from total RNA of undifferentiated 
and differentiated HT29-18 cells gave a specific signal of 
approx. 1.5 kb as previously described for the cell line 
WiDr [7]. The calretinin mRNA signal in the differentiated 
cells was significantly weaker than in the undifferentiated 
HT29-18 cells (Fig. 5). In addition, the specific radioactive 
band was quantified on a Phosphorlmager system. The 
signal in differentiated cells was decreased by approx. 60% 
compared to the undifferentiated cells. 
A B 
Fig. 5. Northern blot analysis of total RNA from HT29-18 cells. (A) 
Ethidium bromide-stained agarose gel (1%). (B) Autoradiogram of the 
nylon membrane probed with a full-length probe of calretinin cDNA. 
HT29-18/glu cells (undifferentiated, left lanes); HT29-18/gal (differen- 
tiated cells, right lanes). 
3.5. DNA cytophotometry and mitotic index 
The percentage of cells in G1 phase of HT29-18/glu 
cells, after 7 days of culture (45 + 4%) and that of HT29- 
18/gal cells, after 26 days of galactose treatment (45 + 
21%) were similar. On the contrary the percentage of cells 
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Fig. 6. DNA content after Feulgen's reaction. Note that the number of cells in G2 plus the polyploid cells is significantly higher in HT29-18/gal (B) than 
in HT29-18/glu (A) cells. In the diagram concerning HT29-18/gal cells, note the peak of cells on the left of the 2c value, indicating cells dying of 
apoptosis. The corresponding mitotic indexes (M.I.: %c) are indicated. The DNA content is expressed in arbitrary units (a.u.). 
R. Cargnello et al. / Biochimica et Biophysica Acta 1313 (1996) 201-208 207 
in G2 phase including polyploid cells determined for 
HT29-18/gal cells (41 _9%)  was significantly higher 
(P  < 0.05) than that calculated for HT29-18/glu cells 
(23 + 3%) (Fig. 6). 
The mitotic index calculated for HT29-18/gal cells was 
3 + 1%o, which turned out 1:o be significantly lower (P  < 
0.05) than that of HT29-18/glu cells, which was 43 +_ 6%~. 
4. Discussion 
The aim of our study was to correlate the expression of 
the EF-hand calcium-binding protein calretinin with the 
state of differentiation of HT29 cells. 
The HT29 cell model is particularly attractive, since it 
is the only cell line of intestinal origin to display structural 
and functional features of mature intestinal epithelial cells 
reversibly. Moreover, cell clones have been isolated that 
exhibit characteristics typical of mature fluid-transporting 
(absorptive) cells [17,19,24]. We have studied the clonal 
cell line HT29-18 which, by the substitution of galactose 
for glucose in the culture medium [19], can differentiate 
into enterocyte-like c lls. 
After 26 days in galactose-containing medium, the ap- 
pearance of a differentiated phenotype was demonstrated 
by the presence of numerous and well organized microvilli 
and by the expression of N-aminopeptidase, a typical 
brush-border marker enzyme [25]. The differentiated cells 
exhibited a carpet of regularly oriented microvilli. Apical 
junctions, typical of absorptive pithelia, were recogniz- 
able between adjacent cell!;. 
By immunohistochemistry we have observed that in 
HT29-18/gal cells, after 26 days in the galactose medium, 
the number of calretinin-immunoreactive cellssignificantly 
dropped compared to undifferentiated HT29-18/glu cells. 
The immunoblot of cytosolic proteins confirmed the re- 
sults of the immunocytochemistry: he signal for calretiniu 
in HT29-18/gal cells was weaker than in HT29-18/glu 
cells. The fact that the calretinin mRNA level was also 
significantly reduced in differentiated cells suggests that 
the control of regulation is at the level of transcription. 
The mechanisms by which the substitution of galactose 
for glucose induces cell differentiation and the reasons 
why a high glucose concentration is necessary to keep the 
cells in their undifferentiated, calretinin-positive, state are 
unclear. Several studies have demonstrated that high glu- 
cose concentrations cause an increase in protein kinase C 
(PKC) levels in cultured cells [26]. PKC stimulation trig- 
gers a complex cascade of phosphorylation a d dephos- 
phorylation events that results in modulation of gene tran- 
scription. A well studied target of PKC stimulation is 
c-fos, an immediate arly gene that appears to be essential 
in many cells for proliferation [27-29]. The expression of 
the c-fos gene is also directly regulated by calcium [30]. 
An involvement of calretinin in the cell cycle has 
already been suggested [7]. Experiments on WiDr cells (a 
derivative of HT29 cells) have shown that the down-regu- 
lation of calretinin using antisense oligodeoxynucleotides, 
leads to the inhibition of the cell cycle and to apoptotic 
events [31]. 
During tumoral transformation of colonic mucosa, ter- 
minal differentiation is abnormal or blocked, and recent 
studies have demonstrated that in some cases the transfor- 
mation of colorectal epithelium to a cancerous form is 
associated with a progressive inhibition of apoptosis [32]. 
We have morphological evidence that a certain number 
of the HT29-18/gal cells die of apoptosis, phenomenon 
that we could not observe in the HT29-18/glu cells (con- 
trol). This fact is confirmed by the data from DNA cy- 
tophotometry: in the diagram concerning HT29-18/gal 
cells, a peak of cells was observed on the left of the 2c 
value [33]. These results are in accordance with the reports 
of Heerdt et al. [34] on apoptosis and cell shedding in 
cultured HT29 colonic carcinoma cells, both in uninduced 
conditions and in the presence of the differentiating agent 
sodium butyrate (NaBT) [15,35-37]. They have found that 
the bulk of cells shed into the medium exhibited signs of 
death by apoptosis. Moreover they have demonstrated that 
both the spontaneously shed apoptotic, and the NaBT-in- 
duced cells were linked to a more differentiated phenotype 
and that the process of apoptosis was most likely initiated 
in the adherent population. All these observations are in 
agreement with the in vivo situation where terminally 
differentiated cells, at the top of the crypt, undergo a 
programmed cell death program and are then extruded into 
the lumen, in order to maintain the homeostasis of the 
colonic mucosa [11,12]. 
Our results demonstrate hat undifferentiated HT29-18 
cells express calretinin, whereas in differentiated cells the 
level of CR mRNA and protein are significantly lower. 
These results would indicate that tumoral transformation 
(carcinogenesis) i  accompanied, among other things, by 
an up-regulation of calretinin expression. 
Among twelve colon adenocarcinoma cell lines which 
we have studied (in preparation) the CaCo-2 and SW1116 
cell lines do not express calretinin. This heterogeneity of 
calretinin expression is also found in human colon adeno- 
carcinomas tudied in situ. In biopsies from primary tu- 
mors, 5-10% were found to express calretinin and most of 
them were classified as grading III. These observations 
show that calretinin expression does not occur in all colon 
cancers, but only in some of them which, from a 
histopathological point of view, correspond to undifferenti- 
ated cancers. In this sense, calretinin expression might 
represent a highly specific tumoral marker. 
The question whether also the expression of other EF- 
hand proteins is up-regulated during neoplastic transforma- 
tion of enterocytes i as yet unknown. In the cell line 
WiDr, a derivative of the cell line HT29, the presence of 
calretinin has been demonstrated before, while no 
immunodetectable levels of calbindin-D28k, parvalbumin, 
S100A6 (calcyclin) or S100/3 were detected [31]. 
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the list of proteins of the EF-hand family is still increasing, 
it can not be ruled out that also other EF-hand proteins are 
present in HT29-18 cells. Their levels as well as the 
concentrations of other proteins which are not involved in 
the regulation of Ca 2+ homeostasis might be affected 
during the differentiation. Van Belzen et al. [38] have used 
the similar cell model HT29-D4 and by subtractive hy- 
bridization techniques they have observed that several 
mRNAs were down-regulated in these cells after differenti- 
ation. 
The question of whether the disappearance of calretinin 
immunoreactivity as well as the decrease in CR mRNA 
and protein in differentiated cells is a prerequisite for, or 
the result of, the differentiation program remains open. 
Experiments will be aimed to demonstrate if the down-reg- 
ulation of calretinin is causally related to the apoptotic 
events observed uring the process of differentiation. 
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